Acceptability of point-of-care viral load testing to facilitate differentiated care: a qualitative assessment of people living with HIV and nurses in South Africa.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
25 Nov 2020
Historique:
received: 28 11 2019
accepted: 18 11 2020
entrez: 26 11 2020
pubmed: 27 11 2020
medline: 15 5 2021
Statut: epublish

Résumé

Providing viral load (VL) results to people living with HIV (PLHIV) on antiretroviral therapy (ART) remains a challenge in low and middle-income countries. Point-of-care (POC) VL testing could improve ART monitoring and the quality and efficiency of differentiated models of HIV care. We assessed the acceptability of POC VL testing within a differentiated care model that involved task-shifting from professional nurses to less highly-trained enrolled nurses, and an option of collecting treatment from a community-based ART delivery programme. We undertook a qualitative sub-study amongst clients on ART and nurses within the STREAM study, a randomized controlled trial of POC VL testing and task-shifting in Durban, South Africa. Between March and August 2018, we conducted 33 semi-structured interviews with clients, professional and enrolled nurses and 4 focus group discussions with clients. Interviews and focus groups were audio recorded, transcribed, translated and thematically analysed. Amongst 55 clients on ART (median age 31, 56% women) and 8 nurses (median age 39, 75% women), POC VL testing and task-shifting to enrolled nurses was acceptable. Both clients and providers reported that POC VL testing yielded practical benefits for PLHIV by reducing the number of clinic visits, saving time, travel costs and days off work. Receiving same-day POC VL results encouraged adherence amongst clients, by enabling them to see immediately if they were 'good' or 'bad' adherers and enabled quick referrals to a community-based ART delivery programme for those with viral suppression. However, there was some concern regarding the impact of POC VL testing on clinic flows when implemented in busy public-sector clinics. Regarding task-shifting, nurses felt that, with extra training, enrolled nurses could help decongest healthcare facilities by quickly issuing ART to stable clients. Clients could not easily distinguish enrolled nurses from professional nurses, instead they highlighted the importance of friendliness, respect and good communication between clients and nurses. POC VL testing combined with task-shifting was acceptable to clients and healthcare providers. Implementation of POC VL testing and task shifting within differentiated care models may help achieve international treatment targets. NCT03066128 , registered 22/02/2017.

Sections du résumé

BACKGROUND BACKGROUND
Providing viral load (VL) results to people living with HIV (PLHIV) on antiretroviral therapy (ART) remains a challenge in low and middle-income countries. Point-of-care (POC) VL testing could improve ART monitoring and the quality and efficiency of differentiated models of HIV care. We assessed the acceptability of POC VL testing within a differentiated care model that involved task-shifting from professional nurses to less highly-trained enrolled nurses, and an option of collecting treatment from a community-based ART delivery programme.
METHODS METHODS
We undertook a qualitative sub-study amongst clients on ART and nurses within the STREAM study, a randomized controlled trial of POC VL testing and task-shifting in Durban, South Africa. Between March and August 2018, we conducted 33 semi-structured interviews with clients, professional and enrolled nurses and 4 focus group discussions with clients. Interviews and focus groups were audio recorded, transcribed, translated and thematically analysed.
RESULTS RESULTS
Amongst 55 clients on ART (median age 31, 56% women) and 8 nurses (median age 39, 75% women), POC VL testing and task-shifting to enrolled nurses was acceptable. Both clients and providers reported that POC VL testing yielded practical benefits for PLHIV by reducing the number of clinic visits, saving time, travel costs and days off work. Receiving same-day POC VL results encouraged adherence amongst clients, by enabling them to see immediately if they were 'good' or 'bad' adherers and enabled quick referrals to a community-based ART delivery programme for those with viral suppression. However, there was some concern regarding the impact of POC VL testing on clinic flows when implemented in busy public-sector clinics. Regarding task-shifting, nurses felt that, with extra training, enrolled nurses could help decongest healthcare facilities by quickly issuing ART to stable clients. Clients could not easily distinguish enrolled nurses from professional nurses, instead they highlighted the importance of friendliness, respect and good communication between clients and nurses.
CONCLUSIONS CONCLUSIONS
POC VL testing combined with task-shifting was acceptable to clients and healthcare providers. Implementation of POC VL testing and task shifting within differentiated care models may help achieve international treatment targets.
TRIAL REGISTRATION BACKGROUND
NCT03066128 , registered 22/02/2017.

Identifiants

pubmed: 33239012
doi: 10.1186/s12913-020-05940-w
pii: 10.1186/s12913-020-05940-w
pmc: PMC7690121
doi:

Banques de données

ClinicalTrials.gov
['NCT03066128']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1081

Subventions

Organisme : US National Institute for Health
ID : AI12471901
Organisme : DST-NRF Centre for HIV Prevention (ZA)
ID : UID96354
Organisme : Wellcome Trust
ID : 216421/Z/19/Z
Pays : United Kingdom

Références

Cochrane Database Syst Rev. 2014 Jul 01;(7):CD007331
pubmed: 24980859
PLoS One. 2017 Jul 27;12(7):e0182005
pubmed: 28750083
Lancet HIV. 2020 Apr;7(4):e229-e237
pubmed: 32105625
BMC Health Serv Res. 2017 Jun 17;17(1):408
pubmed: 28623923
BMC Public Health. 2019 Jun 11;19(1):731
pubmed: 31185962
Lancet. 2012 Sep 8;380(9845):889-98
pubmed: 22901955
AIDS Patient Care STDS. 2008 Mar;22(3):205-12
pubmed: 18290751
Nature. 2015 Dec 3;528(7580):S68-76
pubmed: 26633768
J Int AIDS Soc. 2016 Dec 01;19(1):21484
pubmed: 27914186
Diagnostics (Basel). 2017 Jan 08;7(1):
pubmed: 28075337
AIDS Care. 2019 Apr;31(4):481-488
pubmed: 30078352
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21650
pubmed: 28770594
Med Anthropol. 2017 Jul;36(5):485-499
pubmed: 28379042
J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):194-8
pubmed: 12794554
J Int AIDS Soc. 2017 Nov;20 Suppl 7:
pubmed: 29130621
J Int AIDS Soc. 2014 Jan 20;17:18809
pubmed: 24447595
Trop Med Int Health. 2015 Apr;20(4):430-47
pubmed: 25583302
AIDS. 2018 Jul 17;32(11):1453-1463
pubmed: 29746301
Pract Lab Med. 2015 Dec 09;4:22-29
pubmed: 28856189
PLoS Med. 2018 Aug 13;15(8):e1002636
pubmed: 30102693
PLoS One. 2016 Aug 24;11(8):e0161891
pubmed: 27556894
BMJ Open. 2020 May 15;10(5):e035412
pubmed: 32414827
PLoS One. 2017 Mar 30;12(3):e0174631
pubmed: 28358841
Lancet HIV. 2018 Jan;5(1):e8-e9
pubmed: 29290227
Infect Dis (Auckl). 2013 Dec 09;6:51-60
pubmed: 24847177
Int Nurs Rev. 2019 Mar;66(1):139-146
pubmed: 30184249
Point Care. 2015 Sep;14(3):81-87
pubmed: 26366129
Lancet Infect Dis. 2017 Jan;17(1):e26-e29
pubmed: 27773596
BMJ Open. 2017 Sep 27;7(9):e017507
pubmed: 28963304
Implement Sci. 2012 Jul 16;7:66
pubmed: 22800379
Trop Med Int Health. 2016 Jun;21(6):743-9
pubmed: 27097834
BMC Health Serv Res. 2018 May 11;18(1):363
pubmed: 29751798
Trop Med Int Health. 2015 Apr;20(4):493-500
pubmed: 25496070

Auteurs

Lindani Msimango (L)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.

Andrew Gibbs (A)

Gender and Health Research Unit, South African Medical Research Council, Pretoria, South Africa.
Centre for Rural Health, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.

Hlengiwe Shozi (H)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.

Hope Ngobese (H)

Ethekwini Municipal Health Department, Durban, South Africa.

Hilton Humphries (H)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.

Paul K Drain (PK)

Department of Global Health, Schools of Medicine and Public Health, University of Washington, Seattle, USA.
Department of Medicine, School of Medicine, University of Washington, Seattle, USA.
Department of Epidemiology, School of Public Health, University of Washington, Seattle, USA.

Nigel Garrett (N)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.

Jienchi Dorward (J)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa. Jienchi.Dorward@caprisa.org.
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Jienchi.Dorward@caprisa.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH